SCHEMBL30726730

SCHEMBL30726730

Cc1cc(Nc2cccc(NC(=O)c3cccc(Nc4ccnc5ccccc45)c3)c2)nc(N)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 12/20 1.00
DNMT3A Q9Y6K1 8/20 1.00
DNMT3L Q9UJW3 6/20 1.00
EHMT1 Q9H9B1 3/20 1.00
MYC P01106 1/20 0.78
MAP2K3 P46734 1/20 0.78
EHMT2 Q96KQ7 1/20 0.78
DNMT3B Q9UBC3 1/20 0.78
NPC1 O15118 1/20 0.51
CLK1 P49759 1/20 0.50
MMP1 P03956 1/20 0.47
MMP9 P14780 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPK14 Q16539 1/20 0.45
ROCK1 Q13464 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789536 0.95 DNMT1 (1.00) DNMT1DNMT3ADNMT3LEHMT1MYC
Hydrochloric Acid SCHEMBL1878590 0.95 DNMT1 (0.98) DNMT1DNMT3ADNMT3LEHMT1MYC
SCHEMBL3657042 0.94 DNMT1 (1.00) DNMT1DNMT3ADNMT3LEHMT1MYC
Hydrochloric Acid SCHEMBL1880578 0.93 DNMT1 (0.98) DNMT1DNMT3ADNMT3LEHMT1MYC
SCHEMBL3786360 0.88 DNMT1 (1.00) DNMT1DNMT3ADNMT3LEHMT1MYC
SCHEMBL3655385 0.88 DNMT1 (1.00) DNMT1DNMT3ADNMT3LEHMT1MYC
SCHEMBL29351315 0.88 DNMT1 (1.00) DNMT1DNMT3ADNMT3LEHMT1MYC
Hydrochloric Acid SCHEMBL1886043 0.87 DNMT1 (0.98) DNMT1DNMT3ADNMT3LEHMT1MYC
Hydrochloric Acid SCHEMBL1880676 0.87 DNMT1 (0.98) DNMT1DNMT3ADNMT3LEHMT1MYC
SCHEMBL12240490 0.86 DNMT1 (0.83) DNMT1DNMT3ADNMT3LEHMT1MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025129117-A1 COMPOSITIONS AND METHODS FOR INDUCING MEIOSIS IVY NATAL INC. (US) 2025-06-19 WO claimed
WO-2024226169-A2 METHODS OF PRESERVING VISION AND TREATING VISION LOSS THE SCHEPENS EYE RESEARCH INSTITUTE, INC. (US) 2024-10-31 WO claimed
WO-2025245306-A1 METHODS AND COMPOSITIONS FOR PRODUCING MEIOTIC CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-11-27 WO disclosed
WO-2025129117-A1 COMPOSITIONS AND METHODS FOR INDUCING MEIOSIS IVY NATAL INC. (US) 2025-06-19 WO disclosed
WO-2025049966-A9 METHODS AND COMPOSITIONS FOR INCREASING ROR1 EXPRESSION INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (US) 2025-04-17 WO disclosed
WO-2025049966-A2 METHODS AND COMPOSITIONS FOR INCREASING ROR1 EXPRESSION WASIK MARIUSZ A (US) 2025-03-06 WO disclosed
WO-2024226169-A2 METHODS OF PRESERVING VISION AND TREATING VISION LOSS THE SCHEPENS EYE RESEARCH INSTITUTE, INC. (US) 2024-10-31 WO disclosed
CN-117304092-A DNA methyltransferase 1 inhibitor and preparation method and application thereof 复旦大学 2023-12-29 CN disclosed